ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | G | Leuprorelin acetate - 3.6mg | 8732 | 74016/1 | LEUPRO-SANDOZ | 3.6mg | 1per one month | Implant | SC | Khalil Fattal & Fils S.A.L. | Ever Pharma Jena GmbH | Germany | 11,090,138 L.L | 21.26 | C | Hexal AG | Germany | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L02AE02 | G | Leuprorelin acetate - 3.6mg | 6318 | 166797/11 | LEUPRO-SANDOZ | 3.6mg | 1per one month | Implant | SC | Khalil Fattal & Fils S.A.L. | Ever Pharma Jena GmbH | Germany | 11,090,138 L.L | 21.26 | C | Sandoz Pharmaceuticals GmbH | Germany | 2/5/2024 | 0 |